标题
Use of chemotherapy to treat hepatocellular carcinoma
作者
关键词
-
出版物
BioScience Trends
Volume -, Issue -, Pages -
出版商
International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)
发表日期
2022-02-15
DOI
10.5582/bst.2022.01044
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Disease Primers
- Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Gastroenterology & Hepatology
- Cost-Effectiveness Analysis of Hepatic Arterial Infusion of FOLFOX Combined Sorafenib for Advanced Hepatocellular Carcinoma With Portal Vein Invasion
- (2021) Meiyue Li et al. Frontiers in Oncology
- Hepatic Arterial Infusion Chemotherapy Combined With PD-1 Inhibitors Plus Lenvatinib Versus PD-1 Inhibitors Plus Lenvatinib for Advanced Hepatocellular Carcinoma
- (2021) Jie Mei et al. Frontiers in Oncology
- Advances in immunotherapy for hepatocellular carcinoma
- (2021) Bruno Sangro et al. Nature Reviews Gastroenterology & Hepatology
- Metastatic colorectal cancer: Advances in the folate-fluoropyrimidine chemotherapy backbone
- (2021) Bengt Glimelius et al. CANCER TREATMENT REVIEWS
- The multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus
- (2021) Guoteng Qiu et al. BioScience Trends
- Surgical treatment of hepatocellular carcinoma
- (2021) Yasuhiko Sugawara et al. BioScience Trends
- Efficacy of Combined Therapy with Drug-Eluting Beads-Transcatheter Arterial Chemoembolization Followed by Conventional Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multi-Center Study
- (2021) Asahiro Morishita et al. Cancers
- Arterial chemoembolisation with cisplatin versus epirubicin for hepatocellular carcinoma (ACE 500 study): A multicentre, randomised controlled phase 2/3 trial
- (2021) Osamu Aramaki et al. EUROPEAN JOURNAL OF CANCER
- Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial
- (2021) Qi-Jiong Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Application of iron/barium ferrite/carbon-coated iron nanocrystal composites in transcatheter arterial chemoembolization of hepatocellular carcinoma
- (2021) Peng Zhao et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Molecular therapies for HCC: Looking outside the box
- (2020) Sandrine Faivre et al. JOURNAL OF HEPATOLOGY
- Postoperative Adjuvant Transarterial Infusion Chemotherapy with FOLFOX Could Improve Outcomes of Hepatocellular Carcinoma Patients with Microvascular Invasion: A Preliminary Report of a Phase III, Randomized Controlled Clinical Trial
- (2020) Shaohua Li et al. ANNALS OF SURGICAL ONCOLOGY
- IMbrave 050: a Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation
- (2020) Stephen P Hack et al. Future Oncology
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
- (2020) Matthias Pinter et al. GUT
- Interferons: role in cancer therapy
- (2020) Mohadeseh Haji Abdolvahab et al. Immunotherapy
- Effects of hepatic arterial infusion chemotherapy in the treatment of hepatocellular carcinoma
- (2020) Guan-Bao Long et al. MEDICINE
- Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
- (2020) Kazuomi Ueshima et al. Liver Cancer
- Sorafenib alone vs. sorafenib plus GEMOX as 1st-line treatment for advanced HCC: the phase II randomised PRODIGE 10 trial
- (2019) Eric Assenat et al. BRITISH JOURNAL OF CANCER
- Hepatocellular Carcinoma
- (2019) Augusto Villanueva NEW ENGLAND JOURNAL OF MEDICINE
- Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
- (2019) MinKe He et al. JAMA Oncology
- Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis
- (2019) Chao Li et al. Hepatology International
- Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with RF Ablation Plus Lyso-thermosensitive Liposomal Doxorubicin
- (2019) Haydar Celik et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Lenvatinib Versus Sorafenib as First‐Line Treatment of Unresectable Hepatocellular Carcinoma: A Cost–Utility Analysis
- (2019) John J. Kim et al. ONCOLOGIST
- Molecular genomic landscapes of hepatobiliary cancer
- (2018) Tatsuhiro Shibata et al. CANCER SCIENCE
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
- (2018) Chris Estes et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Transarterial chemoembolization extends long-term survival in patients with unresectable hepatocellular carcinoma
- (2018) Jie-Yu Kong et al. MEDICINE
- The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy
- (2017) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone
- (2016) Karen T. Brown et al. JOURNAL OF CLINICAL ONCOLOGY
- Mechanisms of HBV-induced hepatocellular carcinoma
- (2016) Massimo Levrero et al. JOURNAL OF HEPATOLOGY
- First-line gemcitabine and oxaliplatin (GEMOX) plus sorafenib, followed by sorafenib as maintenance therapy, for patients with advanced hepatocellular carcinoma: a preliminary study
- (2015) Ying Liu et al. International Journal of Clinical Oncology
- SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma
- (2015) Andrew X. Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial
- (2015) Calin Cainap et al. JOURNAL OF CLINICAL ONCOLOGY
- Current Status of Hepatic Arterial Infusion Chemotherapy
- (2015) Shuntaro Obi et al. Liver Cancer
- Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
- (2014) R Golfieri et al. BRITISH JOURNAL OF CANCER
- Development of Hong Kong Liver Cancer Staging System With Treatment Stratification for Patients With Hepatocellular Carcinoma
- (2014) Thomas Yau et al. GASTROENTEROLOGY
- Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib
- (2014) Andrew X. Zhu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide Survey of Primary Liver Cancer in Japan
- (2013) K Nouso et al. BRITISH JOURNAL OF CANCER
- Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
- (2013) Philip J. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia
- (2013) Shukui Qin et al. JOURNAL OF CLINICAL ONCOLOGY
- Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial
- (2013) Ann-Lii Cheng et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Evaluation of Transcatheter Arterial Chemoembolization (TACE) with Multiple Anti-Cancer Drugs (Epirubicin, Cisplatin, Mitomycin C, 5-Fluorouracil) Compared with TACE with Epirubicin for Treatment of Hepatocellular Carcinoma
- (2012) Shinya Sahara et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma
- (2012) Myeong Jun Song et al. JOURNAL OF HEPATOLOGY
- Lyso-thermosensitive liposomal doxorubicin: an adjuvant to increase the cure rate of radiofrequency ablation in liver cancer
- (2011) Ronnie TP Poon et al. Future Oncology
- Sorafenib versus cytotoxic chemotherapy for patients with advanced hepatocellular carcinoma: a retrospective, single-institution study
- (2011) Soohyeon Lee et al. INVESTIGATIONAL NEW DRUGS
- Pegylated liposomal doxorubicin and gemcitabine in patients with advanced hepatocellular carcinoma
- (2010) Giuseppe Lombardi et al. CANCER
- Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)
- (2010) Renumathy Dhanasekaran et al. JOURNAL OF SURGICAL ONCOLOGY
- Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma
- (2009) J. O. Lee et al. ANNALS OF ONCOLOGY
- Prospective Randomized Comparison of Chemoembolization with Doxorubicin-Eluting Beads and Bland Embolization with BeadBlock for Hepatocellular Carcinoma
- (2009) Katerina Malagari et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
- (2009) Johannes Lammer et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Geographic difference in survival outcome for advanced hepatocellular carcinoma: Implications on future clinical trial design
- (2009) Chiun Hsu et al. Contemporary Clinical Trials
- Molecular targeted therapies in hepatocellular carcinoma
- (2008) Josep M. Llovet et al. HEPATOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hepatitis B Virus Infection
- (2008) Jules L. Dienstag NEW ENGLAND JOURNAL OF MEDICINE
- Concept and Clinical Evaluation of Carrier-Mediated Anticancer Agents
- (2008) W. C. Zamboni ONCOLOGIST
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started